医药生物行业周报:业绩修复周期开启,双主线聚焦“创新药+AI医疗”

信达证券
06 May

(以下内容从信达证券《医药生物行业周报:业绩修复周期开启,双主线聚焦“创新药+AI医疗”》研报附件原文摘录)本期内容提要:市场表现:上周(20250428-20250430)医药生物板块收益率为0.49%,板块相对沪深300收益率为0.93%,在31个一级子行业指数中涨跌幅排名第9。6个子板块中,医药商业板块周涨幅最大,涨幅为3.12%(相对沪深300收益率为3.56%);跌幅最大的为生物制品,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10